IBDEI04J ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=KIDNEY/URETER^5^18
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=MALIGNANT NEOPLASMS^6^18
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=COMPLICATIONS^4^18
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=NEURO UROLOGY^7^18
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=BENIGN NEOPLASM-PENIS^2^18
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=SEXUAL DISORDERS^11^18
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=PENILE CONDITIONS^8^18
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=POST OPERATIVE COMPLICATIONS^9^18
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=PROSTATIC CONDITIONS^10^18
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=TESTICULAR CONDITIONS^12^18
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=URETHRAL CONDITIONS^13^18
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=COMMON VASCULAR DX^1^19
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=ABDOMINAL PAIN^2^19
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=AFTERCARE POST SURGERY^3^19
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=CARDIOVASCULAR^4^19
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=METASTATIC CANCER SITES^5^19
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=POST-OP COMPLICATIONS^6^19
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=RESPIRATORY^7^19
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=SIGNS & SYMPTOMS^8^19
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=GENITOURINARY & RENAL^5^20
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=GYNECOLOGICAL/BREAST^6^20
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=CARDIO/VASCULAR^1^20
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=ENDOCRINE/METABOLIC/NUTRITION^2^20
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=EYES/EARS/NOSE^3^20
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=GASTROINTESTINAL^4^20
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=MUSCULOSKELETAL^8^20
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=NEUROLOGY^9^20
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=PULMONARY^10^20
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=PSYCHIATRIC^11^20
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=SKIN^12^20
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=IMMUNIZATIONS^7^20
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=WOUNDS^1^21
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=ARTIFICIAL OPENING^2^21
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=DIABETES^3^21
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=PRESSURE ULCER^4^21
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=SUTURE/DRESSING^5^21
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=RADIATION TREATMENT^1^22
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=RADIATION FOLLOW-UP^2^22
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=BENIGN NEOPLASMS^4^22
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=URINARY TRACT^43^22
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=BREAST-FEMALE^7^22
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=EYE/BRAIN/CNS^14^22
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=CONNECTIVE & SOFT TISSUE^11^22
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=ESOPHAGUS^13^22
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=HYPOPHARYNX^18^22
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=LARYNX^19^22
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=BRONCHUS/LUNG^9^22
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=LYMPHOID/HEMATOPOIETIC^22^22
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=MELANOMA^23^22
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=MOUTH^27^22
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=NASOPHARYNX^28^22
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=OROPHARYNX^29^22
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=PANCREAS^31^22
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=ANUS/ANAL CANAL^3^22
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=SALIVARY GLANDS^35^22
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=SECONDARY MALIG NEOP-OTH SITES^38^22
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=LIP/ORAL CAVITY/PHARYNX^20^22
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=MISCELLANEOUS^26^22
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=PERSONAL HX OF CANCER^32^22
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=MERKEL CELL CARCINOMA^24^22
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=COLON^10^22
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=BREAST-MALE^8^22
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=GENITAL ORGANS-MALE^16^22
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=GENITAL ORGANS-FEMALE^15^22
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=PALATE^30^22
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=STOMACH^41^22
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=SMALL INTESTINE^40^22
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=LIVER/INTRAHEPATIC BILE DUCTS^21^22
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=BILIARY TRACT^5^22
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=DIGESTIVE ORGAN^12^22
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=RESPIRATORY/INTRATHORACIC ORGANS^33^22
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=HEART/MEDIASTINUM/PLEURA^17^22
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=BONE/ARTICULAR CARTILAGE^6^22
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=SKIN^39^22
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=MESOTHELIAL/SOFT TISSUE^25^22
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=RETROPERITONEUM/PERITONEUM^34^22
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=THYROID/ENDOCRINE GLANDS^42^22
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=SECONDARY MALIG NEOP-LYMPH NODES^36^22
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=SECONDARY MALIG NEOP-RESP/DIGESTIVE^37^22
